Gonorrhea (The Clap): Causes, Symptoms, Treatment, and Prevention

What is Gonorrhea (The Clap)?

Gonorrhea is a sexually transmitted infection (STI) caused by the bacterium Neisseria gonorrhoeae. It is most prevalent among young adults, largely due to sexual behavior patterns, and can infect:

• The genital tract
• The mouth and throat
• The rectum (anus)

Transmission occurs during:

• Vaginal intercourse
• Oral sex
• Anal sex

with an infected partner. Ejaculation does not need to occur for the infection to be transmitted.

A pregnant woman with gonorrhea can pass the infection to her baby during childbirth, with potentially serious consequences for the newborn.

Gonorrhea does not always produce obvious symptoms:

• In men, it may cause pain during urination and penile discharge. If untreated, it can cause damage to the prostate and testicles.
• In women, early symptoms are often mild or absent. In more advanced stages, it can cause vaginal bleeding, painful urination, and discharge. Left untreated, it may lead to pelvic inflammatory disease (PID), which can permanently impair fertility and complicate future pregnancies.

Diagnosis is confirmed through laboratory tests, and treatment relies on antibiotics. However, the emergence of antibiotic-resistant strains has made gonorrhea increasingly challenging to treat, raising global alarm among infectious disease specialists.

Gonorrhea is the second most common bacterial STI worldwide, after chlamydia. Millions of new infections occur globally each year. The rise of strains resistant to multiple antibiotics makes this infection a particularly urgent challenge for the medical community.

Key fact: Correct and consistent use of latex condoms significantly reduces, but does not completely eliminate, the risk of gonorrhea transmission.

---

Cause and Transmission

Gonorrhea is caused by the bacterium Neisseria gonorrhoeae, a gram-negative diplococcus that thrives in the warm, moist mucous membranes of the body. It can infect:

• The genital tract (urethra in men; cervix, uterus, and fallopian tubes in women)
• The mouth, throat, and tonsils
• The eyes (conjunctivae)
• The rectum

The infection spreads through direct sexual contact with the penis, vagina, mouth, or anus of an infected person. Ejaculation is not required for transmission to occur, as contact with infected mucosa is sufficient.

Statistically, transmission is more likely to occur from men to women than from women to men, due to anatomical differences in mucosal surface area exposed during intercourse.

Important: Having gonorrhea once does not provide immunity. You can be re-infected with every new exposure to an infected partner.

Infected pregnant women can transmit the bacterium to their newborn during vaginal delivery, potentially causing neonatal ophthalmia (eye infection) or systemic infection.

---

Symptoms

One of the greatest challenges with gonorrhea is that it is frequently asymptomatic. It is estimated that more than half of all infected women and approximately one in five infected men experience no symptoms at all. This is a critical public health problem: individuals without symptoms can unknowingly infect all their sexual partners while also putting themselves at risk of serious complications.

The incubation period, the time between exposure and the onset of symptoms, typically ranges from 1 to 14 days, though it can vary.

In Men

Many infected men remain asymptomatic throughout the course of the infection. When symptoms do appear, they typically include:

• Burning or pain during urination (dysuria)
• White, yellow, or green discharge from the penis
• Increased urinary frequency or urgency

If the infection spreads to the epididymis (the coiled tube at the back of the testicle), a condition known as epididymitis may develop. Symptoms then include:

• Testicular or scrotal pain and swelling
• Tenderness of one or both testicles

Epididymitis requires prompt treatment to prevent long-term fertility complications.

In Women

The majority of women with gonorrhea are asymptomatic. When symptoms do occur, they are often so mild or non-specific that they are easily mistaken for a urinary tract infection (UTI) or a vaginal infection. Possible symptoms include:

• Painful or difficult urination
• Vaginal discharge (which may be yellow or slightly bloody)
• Intermenstrual vaginal bleeding or spotting
• Pelvic or lower abdominal pain (which may indicate early PID)

Critical point: Women with gonorrhea are at risk of developing serious complications regardless of whether or how severe their symptoms are. The absence of symptoms does not mean the infection is not causing internal damage.

Other Sites of Infection

Rectal Infection

Rectal gonorrhea can affect both men and women who engage in receptive anal sex. It is most often completely asymptomatic, but may occasionally present with symptoms consistent with proctitis, such as:

• Rectal discharge
• Anal itching
• Anal or rectal pain
• Rectal bleeding
• Cramping or bowel discomfort

Throat (Pharyngeal) Infection

Pharyngeal gonorrhea is usually asymptomatic, but may sometimes cause a sore throat and mild throat irritation. Because it produces no symptoms in most cases, it is frequently undetected and can serve as a silent reservoir for onward transmission.

Eye Infection (Gonococcal Conjunctivitis)

Although rare in adults, direct inoculation of the eyes with infected genital secretions can cause a severe bacterial conjunctivitis, characterized by redness, swelling, and profuse discharge. This requires urgent treatment to prevent permanent eye damage.

---

Complications

Untreated gonorrhea can cause severe and permanent damage to the reproductive organs of both men and women. The growing prevalence of antibiotic-resistant strains makes timely and appropriate treatment more important than ever.

Complications in Women

• Pelvic Inflammatory Disease (PID): The most serious complication in women. The bacteria ascend from the cervix to the uterus, fallopian tubes, and ovaries. PID can cause permanent scarring of the fallopian tubes, leading to infertility and significantly increasing the risk of ectopic (extrauterine) pregnancy, a life-threatening condition.
• Chronic pelvic pain, which can persist even after the infection has been cleared.

Complications in Men

• Epididymitis: Inflammation of the epididymis, which in rare cases can lead to infertility if both sides are affected.
• Urethral stricture (narrowing of the urethra), which can cause long-term urinary problems.

Disseminated Gonococcal Infection (DGI)

In the most severe and neglected cases, the bacteria enter the bloodstream and spread throughout the body, causing disseminated gonococcal infection (DGI), a potentially life-threatening condition characterized by:

• Reactive arthritis (joint pain and swelling)
• Tenosynovitis (inflammation of tendon sheaths)
• Dermatitis (skin lesions)
• In rare cases, meningitis or endocarditis

Increased HIV Risk

Untreated gonorrhea significantly increases the risk of both acquiring and transmitting HIV. Genital inflammation caused by gonorrhea disrupts the mucosal barrier and recruits immune cells that serve as HIV targets.

During Pregnancy

For pregnant women, untreated gonorrhea substantially increases the risk of:

• Spontaneous miscarriage
• Premature birth
• Low birth weight
• Premature rupture of membranes (PROM)
• Postpartum infection

Babies born to infected mothers are at risk of:

• Neonatal conjunctivitis (ophthalmia neonatorum): A severe eye infection that can cause blindness if not treated immediately
• Septic arthritis: Bacterial joint infection in the newborn
• Neonatal sepsis: A life-threatening bloodstream infection

Recommendation for pregnant women: All pregnant women should be screened for gonorrhea and other STIs early in pregnancy, and again in the third trimester if at high risk.

---

Diagnosis

Modern gonorrhea diagnosis has advanced considerably with molecular technologies that can identify Neisseria gonorrhoeae with exceptional precision, even when bacterial load is low or the patient is asymptomatic. The diagnostic process typically begins with a clinical interview to assess risk factors and symptom history.

Molecular Tests (NAAT)

The gold standard for gonorrhea diagnosis today is Nucleic Acid Amplification Testing (NAAT). These tests detect the bacterium’s DNA or RNA directly from the sample, offering superior sensitivity and specificity compared to older methods.

Sample collection varies by site and gender:

• In men: A first-void urine sample (the very first part of the urine stream, collected after at least 2 hours without urinating) is the preferred non-invasive specimen.
• In women: A vaginal or endocervical swab provides the most accurate results. Current guidelines confirm that self-collected vaginal swabs are equally accurate to clinician-collected samples, improving accessibility and comfort.
• Extra-genital sites: Based on the patient’s reported sexual practices, the clinician may also request pharyngeal (throat) and/or rectal swabs, as infections at these sites are almost always asymptomatic and cannot be detected by urine testing alone.

NAAT results are typically available within 24–72 hours and are the preferred first-line diagnostic approach in most clinical settings.

Culture and Antibiotic Sensitivity Testing

Despite the speed and accuracy of molecular tests, microbiological culture (growing the bacteria in the laboratory from a clinical sample) remains essential in specific situations. It is the only method that allows for a complete antibiogram, testing which antibiotics the specific bacterial strain is still sensitive to.

Culture and sensitivity testing is particularly important when:

• Symptoms persist after treatment (possible treatment failure)
• Antibiotic resistance is suspected or confirmed
• The patient belongs to a population at elevated risk of resistant strains

Gonorrhea culture requires careful handling, as the bacterium is fragile and must be inoculated onto special media promptly.

Full STI Screening

Given the frequent co-occurrence of STIs, any patient who tests positive for gonorrhea should be simultaneously tested for other infections. It is standard clinical practice to screen for:

• Chlamydia (Chlamydia trachomatis)
• Syphilis (Treponema pallidum)
• HIV
• Hepatitis B and C (depending on risk profile)

Reminder: All sexual partners of a confirmed gonorrhea case should also be tested, even if they feel completely well.

---

Treatment

The goal of treatment is the complete eradication of the infection to prevent permanent organ damage and halt transmission to others. Because Neisseria gonorrhoeae has an extraordinary capacity to develop drug resistance, treatment must never be self-managed and must strictly follow current, evidence-based medical protocols.

First-Line Antibiotic Therapy

Current international and national clinical guidelines recommend a single high-dose antibiotic as the preferred treatment:

• Ceftriaxone (intramuscular injection): This remains the most effective and reliable treatment for gonorrhea. The recommended dose has been increased in recent guidelines (typically 1 gram IM as a single dose) to counteract reduced sensitivity in emerging strains. Ceftriaxone is a third-generation cephalosporin and is the cornerstone of current gonorrhea therapy.

• Combination therapy: If co-infection with chlamydia cannot be reliably excluded, the physician will typically add a second antibiotic, most commonly doxycycline (taken orally for 7 days), to cover both infections simultaneously.

• Alternative regimens for penicillin/cephalosporin allergy: In patients with confirmed severe allergy to cephalosporins, alternative protocols using gentamicin (injectable) combined with oral azithromycin may be considered, under strict medical supervision and with subsequent test-of-cure.

Drug resistance warning: Gonorrhea has progressively developed resistance to many previously effective antibiotics, including penicillin, tetracyclines, fluoroquinolones (e.g., ciprofloxacin), and azithromycin when used alone. Never self-medicate. Using the wrong antibiotic or incorrect dosage not only fails to cure the infection but actively contributes to resistance development.

Partner Management and Follow-Up

Treatment is only fully effective if extended to the entire sexual network. It is essential to:

• Notify all sexual partners from the past 60 days prior to diagnosis so they can be tested and treated, even if they have no symptoms whatsoever.
• Abstain from all sexual activity (including oral and anal sex) from the time of diagnosis until both the patient and all partners have completed treatment and are symptom-free.
• Avoid the “ping-pong effect”, which is immediate re-infection from an untreated partner and a common cause of treatment failure.

In certain cases, particularly for pharyngeal infections (which are harder to eradicate) or when symptoms persist, the clinician will request a Test of Cure (TOC): a follow-up NAAT or culture performed approximately 7–14 days after completing therapy to confirm microbiological cure.

Lifestyle and Prevention of Complications

There are no natural remedies, supplements, or dietary changes capable of treating gonorrhea. The infection requires antibiotic treatment, period.

While antibiotics can eliminate the bacterium, they cannot reverse structural damage already caused (such as fallopian tube scarring from PID). This underscores the critical importance of seeking medical attention promptly at the first sign of symptoms or after any unprotected sexual contact with a potentially infected partner.

After successful treatment:

• The patient has no residual immunity and can be re-infected immediately
• Consistent and correct use of condoms remains the most reliable prevention strategy
• Regular STI screening is recommended for sexually active individuals with multiple partners

---

Prevention

Because gonorrhea is transmitted exclusively through sexual contact, prevention strategies focus on reducing exposure:

• Abstinence from sexual activity is the only method that completely eliminates the risk.
• Consistent and correct use of latex or polyurethane condoms during vaginal, anal, and oral sex significantly reduces, but does not entirely eliminate, the risk of transmission, as the bacteria can be present on areas not covered by the condom.
• Limiting the number of sexual partners and maintaining a mutually monogamous relationship with a tested, uninfected partner reduces risk substantially.
• Regular STI screening for sexually active individuals, especially those with multiple or new partners, is essential for early detection and treatment before complications develop or the infection spreads.
• Open communication with partners about sexual health and STI status.
• Pre-exposure counseling by a healthcare provider if you are at elevated risk.

There is currently no vaccine available for gonorrhea, although research into gonococcal vaccine development is ongoing.

---

Key Takeaways

---

References and Bibliography

• CDC – Gonorrhea. Centers for Disease Control and Prevention. https://www.cdc.gov/gonorrhea/about/
• World Health Organization (WHO) – Multi-drug resistant gonorrhoea. https://www.who.int/news-room/fact-sheets/detail/multi-drug-resistant-gonorrhoea
• WHO – Antibiotic-resistant gonorrhoea on the rise; new drugs needed. https://www.who.int/en/news-room/detail/07-07-2017-antibiotic-resistant-gonorrhoea-on-the-rise-new-drugs-needed
• ECDC – Gonorrhoea. European Centre for Disease Prevention and Control. https://www.ecdc.europa.eu/en/gonorrhoea
• Epicentro ISS – Gonorrea. Istituto Superiore di Sanità. https://www.epicentro.iss.it/gonorrea/
• Gonorrhea: Treatment update for an increasingly resistant organism. NCBI/PMC. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4366410/
• Gonorrhea and HIV risk. NCBI/PMC. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4149178/
• Antibiotic-resistant Neisseria gonorrhoeae. PubMed. https://pubmed.ncbi.nlm.nih.gov/24571073/
• Workowski KA, Bachmann LH, Chan PA, et al. Sexually Transmitted Infections Treatment Guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1–187. https://www.cdc.gov/std/treatment-guidelines/default.htm
• European guideline on the diagnosis and treatment of gonorrhoea in adults. International Journal of STD & AIDS. 2021. https://journals.sagepub.com/doi/10.1177/0956462420944724